Ocrelizumab in pediatric multiple sclerosis

European Journal of Paediatric Neurology(2023)

引用 5|浏览13
暂无评分
摘要
Ocrelizumab can be considered a safe and effective treatment option in highly active P-RRMS.
更多
查看译文
关键词
pediatric multiple sclerosis,multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要